Amarin Corp. Plc (AMRN)
13.82
-0.27
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
Amarin Shareholders Equity (Quarterly) : 443.62M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 443.62M |
| March 31, 2026 | 449.41M |
| December 31, 2025 | 459.28M |
| September 30, 2025 | 458.89M |
| June 30, 2025 | 464.92M |
| March 31, 2025 | 473.69M |
| December 31, 2024 | 486.18M |
| September 30, 2024 | 531.38M |
| June 30, 2024 | 551.88M |
| March 31, 2024 | 545.94M |
| December 31, 2023 | 552.10M |
| September 30, 2023 | 553.15M |
| June 30, 2023 | 569.13M |
| March 31, 2023 | 584.79M |
| December 31, 2022 | 595.33M |
| September 30, 2022 | 587.83M |
| June 30, 2022 | 580.04M |
| March 31, 2022 | 641.11M |
| December 31, 2021 | 667.10M |
| September 30, 2021 | 642.50M |
| June 30, 2021 | 645.32M |
| March 31, 2021 | 634.61M |
| December 31, 2020 | 627.50M |
| September 30, 2020 | 607.26M |
| June 30, 2020 | 602.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 585.78M |
| December 31, 2019 | 608.26M |
| September 30, 2019 | 595.90M |
| June 30, 2019 | 149.09M |
| March 31, 2019 | 140.87M |
| December 31, 2018 | 152.33M |
| September 30, 2018 | -52.83M |
| June 30, 2018 | -46.69M |
| March 31, 2018 | -16.66M |
| December 31, 2017 | -65.10M |
| September 30, 2017 | -46.11M |
| June 30, 2017 | -38.74M |
| March 31, 2017 | -28.80M |
| December 31, 2016 | -9.154M |
| September 30, 2016 | 15.19M |
| June 30, 2016 | -164.42M |
| March 31, 2016 | -156.14M |
| December 31, 2015 | -129.19M |
| September 30, 2015 | -111.09M |
| June 30, 2015 | -91.35M |
| March 31, 2015 | -61.82M |
| December 31, 2014 | -88.45M |
| September 30, 2014 | -67.56M |
| June 30, 2014 | -49.98M |
| March 31, 2014 | -57.59M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 3.694B |
| Cellectis SA | 41.07M |
| Alkermes Plc | 1.809B |
| Akari Therapeutics Plc | 18.60M |
| Liquidia Corp. | 195.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 624.36M |
| Total Liabilities (Quarterly) | 180.75M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 3.671 |
| Net Debt Paydown Yield | 0.16% |